A Nigerian pharmacist and doctoral researcher at McGill University, Chika Onochie, has received a research award worth up to CAD $100,000 in Québec, Canada, for his work on developing improved ways to assess male fertility.
Onochie, who is pursuing a PhD in Pharmacology at McGill University, received the funding under the Doctoral Research Scholarships programme of the Fonds de recherche du Québec, following a positive recommendation from a peer-review committee that assessed his application during the Fall 2025 competition.
According to an official award letter from McGill University, the scholarship is valued at CAD $100,000 and will support Onochie’s doctoral research into molecular biomarkers that could provide additional information about male fertility beyond conventional semen analysis.
The award, however, is subject to the adoption of the necessary budgetary appropriations by Québec’s National Assembly and decisions by the Fonds de recherche du Québec board relating to its strategic planning. The funding may also be modified in accordance with the conditions attached to the award.
Onochie’s research focuses on identifying molecular indicators that could help determine whether sperm are functionally capable of fertilising an egg. His work addresses a limitation he has identified in conventional approaches to assessing male fertility, where routine semen analysis may not provide enough information about the functional ability of sperm.
Rather than focusing only on traditional measurements such as sperm count and morphology, the Nigerian researcher is investigating molecular changes in sperm that could potentially provide researchers and clinicians with additional information about sperm function.
His doctoral research is being conducted under the supervision of Professor Cristian O’Flaherty, a reproductive health researcher whose laboratory at McGill University studies the molecular mechanisms involved in sperm production, function and activation, as well as diagnostic approaches to male infertility.
Onochie’s interest in the subject was shaped partly by his professional experience in Nigeria. Before moving to Canada, he trained and worked as a pharmacist and said his experience exposed him to gaps in the way infertility can sometimes be evaluated, particularly in relation to men.
He recalled situations in which women undergoing fertility investigations received extensive medical assessments while evaluation of the male partner could end with a conventional semen analysis.
That experience encouraged him to investigate what existing male fertility tests might not reveal.
Onochie said the issue goes beyond whether men are being overlooked during infertility investigations, arguing that researchers still need reliable biomarkers capable of showing whether sperm are functionally able to fertilise an egg.
He joined McGill University in 2023 to pursue his PhD in Pharmacology, where his research now examines molecular changes in sperm and explores potential functional biomarkers that could eventually contribute to a more comprehensive assessment of male fertility.
The researcher began his academic journey in Nigeria, graduating from the University of Benin in 2021 with First-Class Honours in both Bachelor of Pharmacy and Doctor of Pharmacy degrees. He subsequently worked as a clinical pharmacist before relocating to Canada for doctoral training.
His scientific work has already contributed to published research. In 2025, Onochie co-authored a peer-reviewed review examining redox-induced protein modifications in spermatozoa and how such molecular changes may affect sperm function and male infertility.
For Onochie, the Québec award represents more than financial support for his doctoral programme. He described the recognition as particularly meaningful because much of the foundation of his scientific career was built in Nigeria.
He said receiving the award demonstrates that the education and scientific training he received in Nigeria provided a foundation that enabled him to compete in an international research environment.
The research also carries a broader reproductive-health objective. Onochie hopes his work can eventually contribute to improved tools for understanding male infertility and encourage a more balanced approach to infertility investigations.
He emphasised that infertility should be regarded as an issue involving both partners and argued that improving the assessment of male fertility is important not only from a scientific perspective but also for achieving a more balanced approach to reproductive healthcare.
The CAD $100,000 award therefore provides Onochie with support as he continues his doctoral research while highlighting the work of a Nigerian-trained scientist contributing to reproductive health research at one of Canada’s leading universities.
Although the research is still at the doctoral stage and should not be presented as an established fertility diagnostic breakthrough, its focus on identifying functional biomarkers could contribute to future efforts to understand why conventional testing does not always explain infertility.
Onochie’s achievement adds to a growing body of Nigerian researchers pursuing advanced scientific work internationally, while maintaining links to the academic and professional foundations developed in Nigeria.
